View drug registration information details.


ItemsRegistration information
ID369
No369
Brand NameOMEPAZ
IngredientsOMEPRAZOLE SODIUM EQ. TO OMEPRAZOLE 40 MG
Dosage FormPOWDER FOR SOLUTION FOR INJECTION
Primary PackagingVIAL
Storage
Shelf Life3 YEARS
Pack SizeBOX OF 1 VIAL AND 1 AMPOULE WITH 10 ML WATER FOR INJECTION
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsTREATMENT OF DUODENAL ULCERS, PREVENTION OF RELAPSE OF DUODENAL ULCERS, TREATMENT AND PREVENTION OF RELAPSE OF GASTRIC ULCERS, TREATMENT AND PREVENTION OF NSAID-ASSOCIATED GASTRIC AND DUODENAL ULCERS IN PATIENTS AT RISK, TREATMENT OF REFLUX OESOPHAGITIS, TREATMENT OF ZOLLINGER-ELLISON SYNDROME.
Contraindications
Side Effects
Unit Price
EDL NULL
DescriptionWHITE OR ALMOST WHITE LOOSE POWDER
Note
License OwnerCBF PHARMA CO.,LTD
ManufacturerCISEN PHARMACEUTICAL CO.,LTD
CountryCHINA
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No11 I 3926/13
FDD Registration Date14-AUG-2023
Expiry Date13-AUG-2026

Back to drug list